Abstract
Amitriptyline (AT) and nortriptyline (NT) plasma levels were checked in 86 patients treated with AT by oral or IM administration. Fifty-six patients were also treated with a phenothiazine. In 20 of these patients receiving AT IM with a phenothiazine, the plasma levels of NT (and the variability of these levels between patients) were higher than in nine patients receiving the antidepressant drug alone at the same dosage and by the same route. In eleven patients receiving AT orally with a phenothiazine the plasma levels of NT (and the variability of these levels between patients) were higher, and the ratio of plasma levels of AT and NT were lower than in eight patients receiving the antidepressant drug alone at the same dosage and by the same route. These results suggest an increase of the demethylation of AT and/or a decrease of the hydroxylation of NT and/or a decrease of its elimination. The differences in the variability of the plasma levels of AT and NT could be due to a saturation of the enzymatic system of biotransformation of the antidepressant drug by phenothiazine and to a first-pass effect when the drug is given orally. The correlation between the plasma levels of AT and NT and the clinical effect has been studied in the 86 patients. The correlation between the NT plasma level and the clinical response seems to be more curvilinear when AT is associated with a phenothiazine. This suggests a potentialization of the post-synaptic alpha-receptor blocking effect of NT by the neuroleptic drug.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alvan, G., Borga, O., Lind, M., Palmer, L., Siwers, B.: First pass hydroxylation of nortriptyline: Concentration of parent drug and major metabolites in plasma. Eur. J. Clin. Pharmacol. 11, 219–224 (1977)
Asberg, M., Cronholm, B., Sjoqvist, F., Tuck, D.: Relationship between plasma level and therapeutic effect of nortriptyline. Br. Med. J. 1971 III, 331–334
Braithwaite, R. A., Goulding, R., Theand, G., Bailey, J., Coppen, A.: Plasma concentration of amitriptyline and clinical response. Lancet 1972I, 1296–1300
Coppen, A.: The effective dosage of antidepressants. Postgrad. Méd. J. (Suppl. 3) 52, 72–74 (1976)
Gram, L. F., Over, K. F.: Drug interaction: Inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man. Br. Med. J. I, 463–465 (1972)
Kragh Sorensen, P., Eggert-Hansen, C., Baastrup, P., Hvidberg, E. F.: Self-inhibiting action of nortriptylines antidepressive effect at high plasma levels. Psychopharmacologia 45, 305–312 (1972)
Kragh Sorensen, P., Borga, O., Garle, M., Bolvig Hansen, L., Hansen, C. E., Hvidberg, E. F., Larsen, N. E., Sjoqvist, F.: Effect of simultaneous treatment with low doses of perphenazine on plasma and urine concentrations of nortriptyline and 10-hydroxynortriptyline. Eur. J. Clin. Pharmacol. 11, 479–483 (1977)
Kupfer, D. J., Hanin, I., Spiker, D. G., Grau, T., Coble, P.: Amitriptyline plasma levels and clinical response in primary depression. Clin. Pharmacol. Ther. 22, 904–911 (1977)
Montgomery, S.: The relationship between plasma concentrations of amitriptyline and therapeutic response. Paper read to the British Academy of Psychopharmacology, London, July 1, 1975
Moody, J. P., Tait, A. C., Todrick, A.: Plasma levels of imipramine and demethylimipramine during therapy Br. J. Psychiatry 113, 183–193 (1967)
Olivier Martin, R., Marzin, D., Buschsenschutz, E., Pichot, P., Boissier, J.: Concentrations plasmatiques de l'imipramine et de la demethylimipramine et effet antidépresseur au cours d'un traitement contrôlé. Psychopharmacologia 41, 187–195 (1975)
Potter, W. Z., Goodwin, F. K., Coppen, A.: Correspondence in the Lancet 1978I, 1049–1050
Sorensen, B., Kragh Sorensen, P., Larsen, N. E., Hvidberg, E.: The practical significance of nortriptyline plasma control. Psychopharmacology 59, 35–39 (1978)
Stevenson, I. H., Schiff, A. A.: The effect of fluphenazine on steadystate plasma levels of nortriptyline. Br. J. Clin. Pharmacol. 1, 337–338 (1974)
Tuck, J. R.: Effects of chlorpromazine, thioridazine and haloperidol or adrenergic transmitter mechanisms in man. Eur. J. Clin. Pharmacol. 6, 81–87 (1973)
Vandel, S., Vandel, B., Sandoz, M., Allers, G., Bechtel, P., Volmat, R.: Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline. Eur. J. Clin. Pharmacol. 14, 185–190 (1978)
Volmat, R., Bechtel, P., Allers, G., Vandel, B., Vandel, S.: Mesure de la concentration plasmatique et effet antidépresseur de l'amitriptyline. Therapie 32, 309–319 (1977)
Ziegler, V., Co, B., Taylor, J., Clayton, P., Biggs, J.: Amitriptyline plasma levels and therapeutic response. Clin. Pharmacol. Ther. 19, 795–801 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vandel, B., Vandel, S., Allers, G. et al. Interaction between amitriptyline and phenothiazine in man: Effect on plasma concentration of amitriptyline and its metabolite nortriptyline and the correlation with clinical response. Psychopharmacology 65, 187–190 (1979). https://doi.org/10.1007/BF00433047
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00433047